Desbutyrate Elagolix(CAS: 830346-50-4)

Desbutyrate Elagolix (CAS: 830346-50-4) must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous material classification. Additionally, it falls under the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation. For pharmaceutical compounds like Desbutyrate Elagolix, the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) also have specific requirements regarding safety and environmental impact assessments.

There are several alternatives to Desbutyrate Elagolix (CAS: 830346-50-4) in synthesis, including isomers and analogs. Common alternatives include butyrate elagolix and other related derivatives. These alternatives often serve similar functions but with varying properties, which can be chosen based on specific synthesis requirements and desired outcomes.

The market for Desbutyrate Elagolix (CAS: 830346-50-4) is growing due to its applications in pharmaceutical research, particularly in hormone-related diseases. Research trends focus on understanding its pharmacological properties and safety profiles. Market demand is also influenced by regulatory approvals and clinical trial results, driving further investment in this compound.

Waste containing Desbutyrate Elagolix (CAS: 830346-50-4) should be collected in appropriate containers and handled according to local and international waste management regulations. Proper incineration or professional waste disposal services should be utilized to ensure environmental safety. It is crucial to follow all safety precautions to prevent contamination and ensure compliance with environmental protection standards.